期刊文献+

IL-12对BALB/c小鼠Th17细胞的分化的影响 被引量:1

Detection of Thl7 cells in splenocytes of BALB/c mouse
下载PDF
导出
摘要 目的:观察细胞因子IL-12对Th17细胞分化的影响。方法:小鼠脾淋巴细胞经抗CD3单克隆抗体(mAb)和不同浓度的重组小鼠IL-12刺激,3d后使用ELISA方法观察培养物上清液中IL-17的产生情况。并使用细胞内细胞因子染色的方法,通过流式细胞术观察CD3mAb和重组小鼠IL-12刺激对Th1和Th17细胞分化的影响。结果:Th17细胞不分泌IFN-γ、IL-5、IL-10等细胞因子,不表达Foxp3,是一个独立的细胞亚群。不同浓度的重组小鼠IL-12可以诱导抗CD3mAb的T细胞分泌IFN-γ,并向Th1细胞方向分化。同时,IL-12可以抑制活化的T细胞分泌IL-17,抑制T细胞向Th17细胞分化。结论:IL-12可以抑制Th17细胞的分化。 AIM: To observe the role of IL-12 in Th17 cells differentiation. METHODS: Mouse splenocytes were prepared and cultured with aCD3 alone or plus different concentration of recombined mice IL-12, 3 days later, IL-]7 in the culture supernatant was assayed by ELISA. In addition, Mouse splenocytes were stimulated byαCD3 with or without IL-12 for 48 h, then cell were washed, and restimulated by PMA and Ionomycin, the expression of intracellular IL-17 and IFN-y by CD4^+ and CD8^+ T cells were examined at single cell level by Flow Cytometric analysis. RESULTS: Th-17 cells is a independent cell population, which did not express IL-5, IL-10, IFN-y and Foxp3. IL-12 could induce active mouse T cells produce large amount of IFN-y and the differentiation toward Thl cell. On the contrary, IL-12 could inhabit the production of IL-17 and differentiation toward Th17 cells. CONCLUSION: IL-12 inhabit T cell differentiation toward Th17 cells.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2009年第6期490-492,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金青年基金项目(30600516) 广东省自然科学基金博士启动资金(093008)
关键词 T淋巴细胞 IL-12 TH17细胞 T lymphocytes IL-12 Th17 cells
  • 相关文献

参考文献10

  • 1Infante-Duarte C,Kamradt T.Th1/Th2 balance in infection[J].Springer Semin Immunopathol,1999,21(3):317-338.
  • 2Park H,Li ZX,Yang XO,et al.A distinct lieage of CD4 T cells regulates tissue inflammation by p roducing interleukin 17[J].Nat Immunol,2005,6(11):1133-1141.
  • 3Witowski J,Ksiazek K,Jrres A.Interleukin-17:a mediator of inflammatory responses[J].Cell Mol Life Sci,2004,61(5):567-579.
  • 4Komiyama Y,Nakae S,Matsuki T,et al.IL-17 plays an important role in the development of experimental autoimmune Encephalomyelitis[J].J Immunol,2006,177(1):566-573.
  • 5Rutitzky LI,Stadecker MJ.CD4 T cells producing pro-inflammatory interleukin-17 mediate high pathology in schistosomiasis[J].Mem Inst Oswaldo Cruz,2006,101:327-330.
  • 6Iwakura Y,Ishigame H.The IL-23/IL-17 axis in inflammation[J].J Clin Invest,2006,116(5):1218-1222.
  • 7Yoshimura T,Takeda A,Hamano S,et al.Two-sided roles of IL-27:induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism[J].J Immunol,2006,177(8):5377-5385.
  • 8Weaver CT,Hatton RD,Mangan PR,et al.IL-17 Family cytokines and the expanding diversity of effector T cell lineages[J].Annu Rev Immunol,2007,25:821-852.
  • 9Ferretti S,Bonneau O,Dubois GR,et al.IL-17 produced bylymphocytes and neutrophils is necessary for lipopolysaccharide-induced airway neutrophilia:IL-15 as a possible trigger[J].J Immunol,2003,170:2106-2112.
  • 10Yamazaki S,Inaba K,Tarbell KV,et al.Dendritic cells expand antigen-specific Foxp3+CD25+CD4+regulatory T cells including suppressors of alloreactivity[J].Immunol Rev,2006,212:314-329.

同被引文献19

  • 1Jordanova ES, Gorter A, Ayachi O, et al. Human Leukocyte Antigen Class I , MHC class I chain-related molecule A, and CD8 +/Regulatory T-Cell Ratio: Which Variable Determine Survival of Cervical Cancer Patients [ J ]. Clin Cancer Res, 2008, 14 (7) :2028-2035.
  • 2Watanabe M, Kono K, Kawaguchi Y, et al. Interleukin-21 can efficiently restore impaired antibody-dependent cell-me-diated cytotoxieity in patients with oesophageal squamous cell carcinoma [ J]. Br J Cancer, 2010, 102 (3) :520-529.
  • 3Sakaguchi S. Naturally arising CIM + regulatory t cells for immunologic self-tolerance and negative control of immune responses [ J]. Annu Rev Immunol, 2004, 22:531-562.
  • 4Liyanage UK, Moore TT, Joo HG, et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocar- cinoma [J]. J Immunol, 2002, 169(5):2756-2761.
  • 5Cureil TJ, Coukos G, Zou L, et al. Specific recruitment of regulator T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival [ J ]. Nat Med, 2004, 10(9) :942-949.
  • 6Miyahara Y, Odunsi K, Chen W, et aL Generation and regulation of human CIM + IL-17-producing T cells in ovarian cancer [J]. Proc Natl Acad Sci, 2008, 105(40) :15505- 15510.
  • 7Horlock C, Stott B, Dyson PJ, et al. The effects of trastu- zumab on the CIM + CD25 + FOXP3 + and CIM + IL17A + T-cell axis in patients with breast cancer [ J]. Br J Cancer, 2009, 100(7) :1061-1067.
  • 8Indrovfi M, Bieblova J, Rossowska J, et al. HPV 16-associ- ated tumors: IL-12 can repair the absence of cytotoxic and proliferative responses of tumor infiltrating cells after chemo- therapy [J]. Int J Oneol, 2009, 34(1) :173-179.
  • 9Wolf AM, Rumpold H, Reimer D, et al. High IL-12 p35 and IL-23 p19 mRNA expression is associated with superior outcome in ovarian cancer [ J]. Gynecol Oncol, 2010, 118 (3) :244-250.
  • 10Hashmi MH, Van Veldhuizen PJ. Interleukin-21 : updated review of Phase I and Ⅱ clinical trials in metastatic renal cell carcinoma, metastatic melanoma and relapsed/refraetory indolent non-Hodgkin's lymphoma [J]. Expert Opin Biol Ther, 2010, 10(5) :807-817.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部